CAMK2A Gene

📖 Wiki Page

gene971 wordssynced 2026-04-02

CAMK2A — Calcium/Calmodulin-Dependent Protein Kinase II Alpha

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CAMK2A Gene</th>
</tr>
<tr>
<td class="label">Process</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">[LTP](/mechanisms/long-term-potentiation) induction</td>
<td>CaMKII autophosphorylation at T286</td>
</tr>
<tr>
<td class="label">LTD induction</td>
<td>Protein phosphatases reverse CaMKII action</td>
</tr>
<tr>
<td class="label">[LTP](/mechanisms/long-term-potentiation) maintenance</td>
<td>Persistent CaMKII activity</td>
</tr>
<tr>
<td class="label">Memory consolidation</td>
<td>CREB activation, gene transcription</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">CaMKII inhibitors</td>
<td>KN-62, AIP</td>
</tr>
<tr>
<td class="label">CaMKII activators</td>
<td>Peptide fragments</td>
</tr>
<tr>
<td class="label">BDNF analogs</td>
<td>BDNF, NT-3</td>
</tr>
<tr>
<td class="label">PDE inhibitors</td>
<td>Ibudilast</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-CAMK2A</td>
</tr>
<tr>
<td class="label">Biomarker</td>
<td>Sample</td>
</tr>
<tr>
<td class="label">p-CaMKII (T286)</td>
<td>Brain tissue, CSF</td>
</tr>
<tr>
<td class="label">CaMKII activity</td>
<td>Brain tissue</td>
</tr>
<tr>
<td class="label">p-NR2B (S1303)</td>
<td>Brain tissue</td>
</tr>
<

...

CAMK2A — Calcium/Calmodulin-Dependent Protein Kinase II Alpha

Introduction

Camk2A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

The CAMK2A gene encodes the alpha subunit of Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII), one of the most abundant proteins in the brain, constituting up to 2% of total brain protein. CaMKII is a serine/threonine protein kinase that functions as a molecular decoder of calcium signals, playing essential roles in synaptic plasticity, learning, and memory. The CAMK2A isoform is predominantly expressed in excitatory [neurons](/entities/neurons) of the forebrain, particularly in the hippocampus and cerebral cortex. Dysregulation of CaMKII signaling is implicated in Alzheimer's disease, Parkinson's disease, epilepsy, intellectual disability, and various other neurological disorders.

Gene Structure

Gene length: ~95 kb
Exons: 13 coding exons
Promoter: Activity-dependent, regulated by CREB
Alternative splicing: Generates multiple isoforms

Isoforms

CaMKIIα: Brain-specific, 12 subunits
CaMKIIβ: Brain and muscle, regulates localization
CaMKIIγ/δ: Ubiquitous expression

Protein Structure

CaMKII forms a holoenzyme with 12 subunits arranged in two stacked hexameric rings:

Subunit Structure

N-terminal catalytic domain: Kinase activity
Regulatory domain: Autoinhibitory, calmodulin-binding
Association domain: Multimerization
C-terminal variable region: Targeting elements

Key Features

T286 autophosphorylation: Calcium-independent activity
T305/T306: Inhibition of calmodulin binding
F506: F-site for calmodulin trapping

Normal Function

Synaptic Plasticity

Molecular Mechanisms

Calcium influx: [NMDA](/entities/nmda-receptor) receptors, voltage-gated calcium channels

Calmodulin binding: Calcium-calmodulin activates CaMKII

Autophosphorylation: T286 becomes phosphorylated

Calcium-independent activity: Truncated CaMKII remains active

Substrate phosphorylation: NR2B, AMPA receptors, CREB

Synaptic targeting: PSD-95, NMDA receptor complexes

Brain Region Distribution

Hippocampus: Highest expression in CA1 and CA3 pyramidal neurons
Cerebral cortex: Layers II-III and V pyramidal neurons
Striatum: Medium spiny neurons
Amygdala: Principal neurons
Thalamus: Relay neurons

Cell Type Specificity

Excitatory glutamatergic neurons: Very high
Inhibitory GABAergic neurons: Low
[Astrocytes](/entities/astrocytes): Minimal
Oligodendrocytes: Minimal

Role in Neurodegeneration

Alzheimer's Disease

CaMKII signaling is significantly impaired in Alzheimer's disease at multiple levels:

Reduced CaMKII activity: Postmortem AD brain shows 40-60% reduction
[Tau](/proteins/tau) hyperphosphorylation: CaMKII can phosphorylate [tau](/proteins/tau) at multiple sites (Ser262, Thr231)
Synaptic dysfunction: Impaired LTP correlates with memory deficits
[Aβ](/proteins/amyloid-beta) toxicity: Aβ oligomers disrupt CaMKII localization
NMDA receptor dysregulation: Altered NR2B phosphorylation

Therapeutic strategies:

CaMKII activators (experimental)
BDNF to restore CaMKII signaling
PDE inhibitors to enhance cAMP/CaMKII pathway

Parkinson's Disease

Dopaminergic signaling: CaMKII modulates D1/D2 receptor signaling
L-DOPA-induced dyskinesia: CaMKII hyperactivity in striatum
[α-synuclein](/proteins/alpha-synuclein) toxicity: CaMKII may phosphorylate α-syn
Neuroprotection: CaMKII activation provides dopaminergic protection

Epilepsy

Gain-of-function mutations: Cause early-onset epileptic encephalopathy
Seizure-induced activation: CaMKII upregulation after seizures
Synaptic hyperexcitability: Enhanced glutamate release
Therapeutic targeting: CaMKII inhibitors in development

Intellectual Disability and Autism

De novo mutations: Associated with ID and ASD
Synaptic dysfunction: Impaired activity-dependent plasticity
Cognitive deficits: Memory and learning impairments

Stroke and Traumatic Brain Injury

Ischemic injury: CaMKII activation during ischemia
Excitotoxicity: Excessive calcium influx dysregulates CaMKII
Neuroprotection: CaMKII inhibition may reduce damage
Recovery: CaMKII activity important for rehabilitation

Therapeutic Targeting

Challenges

CNS penetration: Many inhibitors don't cross BBB
Isoform specificity: Pan-CaMKII vs isoform-selective
Therapeutic window: Both too much and too little are problematic

Biomarkers

Animal Models

Knockout Mice

Camk2a null: LTP deficits, spatial memory impairment
T286A knockin: LTP impairment, no memory consolidation

Transgenic Models

CaMKIIa-Cre: Neuron-specific expression
Conditional knockout: Temporal control of deletion

Disease Models

5xFAD mice: CaMKII deficits
α-syn models: CaMKII activation studies
TBI models: CaMKII in injury and recovery

Research Directions

[Blood-brain barrier](/entities/blood-brain-barrier) penetrating CaMKII modulators
Activity-dependent CaMKII monitoring
Personalized medicine based on CAMK2A variants
Combination therapies targeting multiple synaptic pathways
Gene therapy for CAMK2A deficiency

External Links

[NCBI Gene: CAMK2A](https://www.ncbi.nlm.nih.gov/gene/815)
[UniProt: CaMKII alpha](https://www.uniprot.org/uniprot/Q9UQF2)
[Human Protein Atlas: CAMK2A](https://www.proteinatlas.org/ENSG00000108697-CAMK2A)

Background

References

[Lisman J, et al., The molecular basis of CaMKII function in synaptic plasticity and memory (2002)](https://pubmed.ncbi.nlm.nih.gov/11963140/)

[Soderling TR, et al., Regulation of the CaMKII and its function in synaptic plasticity (2001)](https://pubmed.ncbi.nlm.nih.gov/11399428/)

[Bayer KU, et al., Transition from Ca2+/calmodulin-dependent to Ca2+-independent CaMKII activation in neuronal plasticity (2023)](https://pubmed.ncbi.nlm.nih.gov/37120651/)

[Ghosh A, et al., CaMKII dysfunction in Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35181783/)

[Robison AJ, et al., CaMKII in Parkinson's disease and L-DOPA-induced dyskinesia (2021)](https://pubmed.ncbi.nlm.nih.gov/34047289/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CAMK2A Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

CAMK2A Gene

CAMK2A — Calcium/Calmodulin-Dependent Protein Kinase II Alpha

CAMK2A — Calcium/Calmodulin-Dependent Protein Kinase II Alpha

Introduction

Overview

Gene Structure

Isoforms

Protein Structure

Subunit Structure

Key Features

Normal Function

Synaptic Plasticity

Molecular Mechanisms

Brain Region Distribution

Cell Type Specificity

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Epilepsy

Intellectual Disability and Autism

Stroke and Traumatic Brain Injury

Therapeutic Targeting

Challenges

Biomarkers

Animal Models

Knockout Mice

Transgenic Models

Disease Models

Research Directions

See Also

See Also

External Links

Background

References

Pathway Diagram